Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer (RESToRE)

Courtney deGorterParticipate in Research

Actively recruiting in Vancouver, BC.

Inclusion Criteria:

  • Individuals are postmenopausal (must be three (3) years past last menstrual period)
  • Individuals have an intact uterus (have not had a hysterectomy)

Exclusion Criteria:

  • Individuals taking hormone therapy for menopause (including vaginal estrogen)
  • Individuals taking male hormones,
  • Individuals on anti-endocrine therapy (such as tamoxifen)
  • Individuals on aromatase inhibitor therapy
  • Individuals who have experienced abnormal uterine bleeding
  • Individuals who have an Intrauterine Device (IUD)

For more information read here: https://clinicaltrials.gov/study/NCT05651282?locStr=Canada&country=Canada&cond=Women%27s%20Health&aggFilters=status:rec&rank=1